GP

Guillaume Pfefer

VC Partner, CEO Partner at Flagship Pioneering

Location

United States, North America

Check Size

$500K - $15M

Investment Stage

Seed
Series A

Focus Areas

Health IT
Health & Hospital Services
BioTech
Enterprise
Manufacturing
Pharmaceuticals

About Investor

Guillaume Pfefer is CEO Partner at Flagship Pioneering in Cambridge, deploying $500K–$15M into seed and Series A pharmaceuticals, biotech, manufacturing, health IT, and enterprise ventures. His most recent investment is Senda Biosciences via Flagship, now part of Sail Biomedicines. He formerly led global vaccine strategy at GSK (including Shingrix), has 25 years in biotech, and now steers Flagship’s incubator-model innovation.

Looking for investors like Guillaume Pfefer?
Get matched with the right ones for your startup.

Explore more investors

Previous investments

Senda Biosciences
120M |2022

Similar Investors

AL

Abdul Ly

United States, North America
$1M - $4M

Seed

,

Series A

,
PS

Paul Straub

United States, North America
$100K - $2M

Pre Seed

,

Seed

,
SA

Shaun Abrahamson

United States, North America
$250K - $1M

Pre Seed

,

Seed

,
RF

Riley Florsheim

United States, North America
$100K - $5M

Pre Seed

,

Seed

,
SB

Steve Brownlie

United States, North America
$250K - $1.4M

Pre Seed

,

Seed

,
JR

JJ Richa

United States, North America
$50K - $1M

Pre Seed

,

Seed

,

Is this You?

Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors

This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.

Start Matching For Free